Author

Prakash P

Professor of Medicine, UCSF School of Medicine, San Francisco,CA - Cited by 1,24,217 - Cardiovascular diseases - Diabets - Hypertension - Heart Failure - Preventive Cardiology

Biography

Prakash P, Tata Institute of Social Sciences School of Development Studies, India. He  has published more than 30 articles, In the field of Environment, Geospatial Science, Natural Disasters,Earth Sciences, Geographic Information System. 
Title
Cited by
Year
Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association
SV Arnold, DL Bhatt, GW Barsness, AL Beatty, PC Deedwania, ...Circulation 141 (19), e779-e806, 2020202
154
2020
Prevalence of hypertension among Indian adults: results from the great India blood pressure survey
S Ramakrishnan, G Zachariah, K Gupta, JS Rao, PP Mohanan, ...Indian heart journal 71 (4), 309-313, 2019201
150
2019
Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the American Heart Association
JJ Joseph, P Deedwania, T Acharya, D Aguilar, DL Bhatt, DA Chyun, ...Circulation 145 (9), e722-e759, 2022202
117
2022
Therapeutic inertia in cardiovascular disease prevention: time to move the bar
DL Dixon, G Sharma, PB Sandesara, E Yang, LT Braun, GA Mensah, ...Journal of the American College of Cardiology 74 (13), 1728-1731, 2019201
48
2019
Efficacy and safety of PCSK9 inhibition with evolocumab in reducing cardiovascular events in patients with metabolic syndrome receiving statin therapy: secondary analysis from …
P Deedwania, SA Murphy, A Scheen, J Badariene, AL Pineda, ...JAMA cardiology 6 (2), 139-147, 2021202
40
2021
Loop diuretic prescription and 30-day outcomes in older patients with heart failure
C Faselis, C Arundel, S Patel, PH Lam, SS Gottlieb, MR Zile, ...Journal of the American College of Cardiology 76 (6), 669-679, 2020202
38
2020
Sodium glucose co-transporter 2 inhibitors and heart failure
RK Ghosh, GC Ghosh, M Gupta, D Bandyopadhyay, T Akhtar, ...The American Journal of Cardiology 124 (11), 1790-1796, 2019201
37
2019
American Heart Association Council on Lifestyle and Cardiometabolic Health and Council on Clinical Cardiology. Clinical management of stable coronary artery disease in patients …
SV Arnold, DL Bhatt, GW Barsness, AL Beatty, PC Deedwania, ...Circulation 141 (19), e779-e806, 2020202
32
2020
Strategies for promotion of a healthy lifestyle in clinical settings: pillars of ideal cardiovascular health: a science advisory from the American Heart Association
PM Kris-Etherton, KS Petersen, JP Després, CAM Anderson, ...Circulation 144 (24), e495-e514, 2021202
31
2021
Gout pharmacotherapy in cardiovascular diseases: a review of utility and outcomes
S Kaul, M Gupta, D Bandyopadhyay, A Hajra, P Deedwania, E Roddy, ...American Journal of Cardiovascular Drugs, 1-14, 2020202
29
2020
Fish oil and cardiometabolic diseases: recent updates and controversies
R Tummala, RK Ghosh, V Jain, AR Devanabanda, D Bandyopadhyay, ...The American journal of medicine 132 (10), 1153-1159, 2019201
24
2019
Trends of cardiac complications in patients with rheumatoid arthritis: analysis of the United States National Inpatient Sample; 2005-2014
D Bandyopadhyay, U Banerjee, A Hajra, S Chakraborty, B Amgai, ...Current problems in cardiology 46 (3), 100455, 2021202
23
2021
Association between depression and readmission of heart failure: a national representative database study
N Patel, S Chakraborty, D Bandyopadhyay, B Amgai, A Hajra, V Atti, ...Progress in Cardiovascular Diseases 63 (5), 585-590, 2020202
23
2020
Digoxin initiation and outcomes in patients with heart failure (HFrEF and HFpEF) and atrial fibrillation
S Singh, H Moore, PE Karasik, PH Lam, S Wopperer, C Arundel, ...The American Journal of Medicine 133 (12), 1460-1470, 2020202
19
2020
Systolic blood pressure and outcomes in older patients with HFpEF and hypertension
C Faselis, PH Lam, MR Zile, P Bhyan, A Tsimploulis, C Arundel, S Patel, ...The American journal of medicine 4 (4), e252-e263, 2021202
13
2021
Efficacy and Safety of Long-Term Evolocumab Use Among Asian Subjects―A Subgroup Analysis of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With …
AC Keech, K Oyama, PS Sever, M Tang, SA Murphy, A Hirayama, C Lu, ...Circulation Journal 85 (11), 2063-2070, 2021202
12
2021
Impact of the 2017 ACC/AHA guidelines on the prevalence of hypertension among Indian adults: Results from a cross-sectional survey
K Gupta, S Ramakrishnan, G Zachariah, JS Rao, PP Mohanan, ...International Journal of Cardiology Hypertension 7, 100055, 2020202
9
2020
Loop diuretic prescription and long-term outcomes in heart failure: association modification by congestion
C Faselis, PH Lam, S Patel, C Arundel, G Filippatos, P Deedwania, ...The American Journal of Medicine 134 (6), 797-04, 2021202
8
2021
Aspirin for primary prevention of coronary artery disease
A Ujjawal, M Gupta, RK Ghosh, V Jain, D Bandyopadhyay, A Qamar, ...Current Problems in Cardiology 46 (3), 100553, 2021202
7
2021
Cardiovascular Impact of Race and Ethnicity in Patients With Diabetes and Obesity: JACC Focus Seminar 2/9
JJ Joseph, R Ortiz, T Acharya, SH Golden, L López, P DeedwaniaJournal of the American College of Cardiology 8 (24), 241-2482, 2021202
7
2021

Referred From: https://scholar.google.com/citations?hl=en&user=N21P1lsAAAAJ

Cited by
Citations 124217
h-index 92
i10-index 322
Recommended Journals
Open Access Journals